Basophil recruitment into tumor-draining lymph nodes correlates with Th2 inflammation and reduced survival in pancreatic cancer patients

Cancer Research

Volumn 76, Issue 7, 2016, Pages 1792-1803

  De Monte, Lucia ^a   Wörmann, Sonja ^b   Brunetto, Emanuela ^a,c   Heltai, Silvia ^a,c   Magliacane, Gilda ^a   Reni, Michele ^a   Paganoni, Anna Maria ^d   Recalde, Helios ^e   Mondino, Anna ^a   Falconi, Massimo ^a,c   Aleotti, Francesca ^a   Balzano, Gianpaolo ^a   Algül, Hana ^b   Doglioni, Claudio ^a,c   Protti, Maria Pia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d POLITECNICO DI MILANO   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN 2; INTERLEUKIN 3; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 3;

AGED; ARTICLE; BASOPHIL; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MONOCYTE; NONHUMAN; PANCREAS ADENOCARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TUMOR MICROENVIRONMENT; UPREGULATION; IMMUNOLOGY; INFLAMMATION; LYMPH NODE; METABOLISM; MIDDLE AGED; MORTALITY; PANCREAS CARCINOMA; PATHOLOGY; RETROSPECTIVE STUDY;

AGED; BASOPHILS; CARCINOMA, PANCREATIC DUCTAL; HUMANS; INFLAMMATION; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TH2 CELLS;

EID: 84963778169     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-1801-T     Document Type: Article

References (50)

1. Hidalgo M. Pancreatic cancer. N Engl J Med 2010;362:1605-17.
2. Kleeff J, Beckhove P, Esposito I, Herzig S, Huber PE, Lohr JM, et al. Pancreatic cancer microenvironment. Int J Cancer 2007;121:699-705.
3. Feig C, Gopinathan A, Neesse A, Chan DS, Cook N, Tuveson DA. The pancreas cancer microenvironment. Clin Cancer Res 2012;18:4266-76.
4. Vonderheide RH, Bayne LJ. Inflammatory networks and immune surveillance of pancreatic carcinoma. Curr Opin Immunol 2013;25:200-5.
5. Wormann SM, Diakopoulos KN, Lesina M, Algul H. The immune network in pancreatic cancer development and progression. Oncogene 2014;33:2956-67.
6. Erkan M, Hausmann S, Michalski CW, Fingerle AA, Dobritz M, Kleeff J, et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol 2012;9:454-67.
7. Protti MP, De Monte L. Immune infiltrates as predictive markers of survival in pancreatic cancer patients. Front Physiol 2013;4:210.
8. Zheng L, Xue J, Jaffee EM, Habtezion A. Role of immune cells and immunebased therapies in pancreatitis and pancreatic ductal adenocarcinoma. Gastroenterology 2013;144:1230-40.
9. De Monte L, Reni M, Tassi E, Clavenna D, Papa I, Recalde H, et al. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med 2011;208:469-78.
10. Protti MP, De Monte L. Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer. Oncoimmunology 2012;1:89-91.
11. Paul WE, Zhu J. How are T (H) 2-type immune responses initiated and amplified? Nat Rev Immunol 2010;10:225-35.
12. Forbes E, van Panhuys N, Min B, Le Gros G. Differential requirements for IL-4/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses. Immunol Cell Biol 2010;88:240-3.
13. Ho IC, Tai TS, Pai SY. GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol 2009;9:125-35.
14. Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt Rde W, et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 2007;25:193-219.
15. Tjota MY, Sperling AI. Distinct dendritic cell subsets actively induce Th2 polarization. Curr Opin Immunol 2014;31:44-50.
16. Min B, Paul WE. Basophils and type 2 immunity. Curr Opin Hematol 2008;15:59-63.
17. Karasuyama H, Mukai K, Obata K, Tsujimura Y, Wada T. Nonredundant roles of basophils in immunity. Ann Rev Immunol 2011;29:45-69.
18. Marone G, Borriello F, Varricchi G, Genovese A, Granata F. Basophils: historical reflections and perspectives. Chem Immunol Allergy 2014;100:172-92.
19. Evans DB, Charnsangavei C, Fernandez-del-Castillo C, Fong Y, Lauwers GY, et al. Exocrine pancreas. In: Greene FL, Page D, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. editors. AJCC cancer staging manual. 6th ed. New York, NY: Springer;2002. p. 157-64.
20. Ohnmacht C, Schwartz C, Panzer M, Schiedewitz I, Naumann R, Voehringer D. Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. Immunity 2010;33:364-74.
21. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, Montoya R, et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001;15:3243-8.
22. Nakhai H, Sel S, Favor J, Mendoza-Torres L, Paulsen F, Duncker GI, et al. Ptf1a is essential for the differentiation of GABAergic and glycinergic amacrine cells and horizontal cells in the mouse retina. Development 2007;134:1151-60.
23. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 2001;29:418-25.
24. Tassi E, Gavazzi F, Albarello L, Senyukov V, Longhi R, Dellabona P, et al. Carcinoembryonic antigen-specific but not antiviral CD4+ T cell immunity is impaired in pancreatic carcinoma patients. J Immunol 2008;181:6595-603.
25. Leonard EJ, Roberts RL, Skeel A. Purification of human blood basophils by single step isopycnic banding on Percoll. J Leukoc Biol 1984;35:169-77.
26. Hauswirth AW, Sonneck K, Florian S, Krauth MT, Bohm A, Sperr WR, et al. Interleukin-3 promotes the expression of E-NPP3/CD203C on human blood basophils in healthy subjects and in patients with birch pollen allergy. Int J Immunopathol Pharmacol 2007;20:267-78.
27. Kleine-Tebbe J, Erdmann S, Knol EF, MacGlashan DW Jr, Poulsen LK, Gibbs BF. Diagnostic tests based on human basophils: potentials, pitfalls and perspectives. Int Arch Allergy Immunol 2006;141:79-90.
28. Suzukawa M, Hirai K, Iikura M, Nagase H, Komiya A, Yoshimura-Uchiyama C, et al. IgE-and FcepsilonRI-mediated migration of human basophils. Int Immunol 2005;17:1249-55.
29. Plager DA, Weiss EA, Kephart GM, Mocharla RM, Matsumoto R, Checkel JL, et al. Identification of basophils by a mAb directed against pro-major basic protein 1. J Allergy Clin Immunol 2006;117:626-34.
30. Poorafshar M, Helmby H, Troye-Blomberg M, Hellman L. MMCP-8, the first lineage-specific differentiation marker for mouse basophils. Elevated numbers of potent IL-4-producing and MMCP-8-positive cells in spleens of malaria-infected mice. Eur J Immunol 2000;30:2660-8.
31. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993;177:605-11.
32. Gibbs BF, Haas H, Falcone FH, AlbrechtC, Vollrath IB, Noll T, et al. Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation. Eur J Immunol 1996;26:2493-8.
33. Leyva-Castillo JM, Hener P, Michea P, Karasuyama H, Chan S, Soumelis V, et al. Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade. Nat Commun 2013;4:2847.
34. Dahinden CA, Geiser T, Brunner T, von Tscharner V, Caput D, Ferrara P, et al. Monocyte chemotactic protein 3 is a most effective basophil-and eosinophil-activating chemokine. J Exp Med 1994;179:751-6.
35. Tang H, Cao W, Kasturi SP, Ravindran R, Nakaya HI, Kundu K, et al. The T helper type 2 response to cysteine proteases requires dendritic cellbasophil cooperation via ROS-mediated signaling. Nat Immunol 2010;11:608-17.
36. Galdiero MR, Garlanda C, Jaillon S, Marone G, Mantovani A. Tumor associated macrophages and neutrophils in tumor progression. J Cell Physiol 2013;228:1404-12.
37. Valent P, Dahinden CA. Role of interleukins in the regulation of basophil development and secretion. Curr Opin Hematol 2010;17:60-6.
38. Siracusa MC, Comeau MR, Artis D. New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation. Ann N Y Acad Sci 2011;1217:166-77.
39. Cai SW, Yang SZ, Gao J, Pan K, Chen JY, Wang YL, et al. Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma. Surgery 2011;149:576-84.
40. Chang DZ, Ma Y, Ji B, Wang H, Deng D, Liu Y, et al. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clin Cancer Res 2011;17:7015-23.
41. Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F, et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 2004;57:630-6.
42. Strouch MJ, Cheon EC, Salabat MR, Krantz SB, Gounaris E, Melstrom LG, et al. Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res 2010;16:2257-65.
43. Schonhuber N, Seidler B, Schuck K, Veltkamp C, Schachtler C, Zukowska M, et al. A next-generation dual-recombinase system for time-and hostspecific targeting of pancreatic cancer. Nat Med 2014;20:1340-7.
44. SiracusaMC, Wojno ED, Artis D. Functional heterogeneity in the basophil cell lineage. Adv Immunol 2012;115:141-59.
45. Siracusa MC, Saenz SA, Hill DA, Kim BS, Headley MB, Doering TA, et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 2011;477:229-33.
46. Sixt M, Kanazawa N, Selg M, Samson T, Roos G, Reinhardt DP, et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 2005;22:19-29.
47. Borriello F, LongoM, Spinelli R, Pecoraro A, Granata F, Staiano RI, et al. IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes. Eur J Immunol 2015;45:2042-51.
48. Schroeder JT, Chichester KL, Bieneman AP. Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease. J Immunol 2009;182:2432-8.
49. Burris HA III, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997;15:2403-13.
50. Reni M, Cordio S, Milandri C, Passoni P, Bonetto E, Oliani C, et al. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlledmulticentre phase III trial. Lancet Oncol 2005;6:369-76.